... apoptotic cells in the total PBMC population at 24 hours, as measured by annexinV staining (median [interquartile range]: 3 .25 % [2. 25–5 .15 %] versus 2. 20% [1. 7–3.35%], P = 0. 0 12 ; Figure 1a) The TGFβAI ... an individual The TGF- 1 activation indices were similar between patients and control individuals (median [interquartile range] AI: 1. 63 [1. 31 1. 88] in SLE patients versus 1. 50 [1. 26 1. 73] in ... dissolution with plasmin Nature Medicine 19 95, 1: 9 32- 937 20 Lawrence DA: Latent-TGF-beta: an overview Mol Cell Biochem 20 01, 21 9 :16 3 -17 0 21 Emlen W, Niebur J, Kadera R: Accelerated in vitro apoptosis...
... Therapy 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Vol No Yamasaki et al human and murine autoimmune sera to U1 small nuclear ribonucleoprotein C protein J Clin Invest 19 96, 97 :2 619 -26 26 ... serially diluted 1: 5, starting from 1: 500 dilutions All sera were clearly positive on ELISA and their titers were 1: 12, 500 in one case, 1: 62, 500 in six, and 1: 3 12 ,500 in two, indicating that the ... screened by ELISA with the recombinant RPA 32 protein Antibodies against RPA 32 were found in 10 .9% (87 of 8 01) in breast cancer patients andin 10 .3% (4 of 39) in intraductal in situ carcinoma patients,...
... levels of Th17-driving cytokinesand IL -10 in patients with SLE and healthy controls Plasma levels of Th17-polarizing cytokinesg(IL-1b, IL-6, IL- 21 , TGF-b, and IL -23 ) and IL -10 were measured in patients ... TGF-b, IL-1b, IL-6, IL- 21 , and IL -23 are involved in developing and/ or expanding Th17 cells, whereas IFN-g and IL-4, signature cytokines required for Th1 and Th2 differentiation, suppress Th17 cell ... they have no competing interests 20 Received: 26 October 20 09 Revised: 15 January 2 010 Accepted: 24 March 2 010 Published: 24 March 2 010 21 References Vratsanos G, Kang I, Craft J: Systemic lupus...